Your browser doesn't support javascript.
Snapshot PCR surveillance for SARS-CoV-2 in hospital staff in England.
Brown, Colin S; Clare, Kathryn; Chand, Meera; Andrews, Julie; Auckland, Cressida; Beshir, Sarah; Choudhry, Saher; Davies, Kerrie; Freeman, Jane; Gallini, Andrew; Moores, Rachel; Patel, Trupti; Poznalska, Gosia; Rodger, Alison; Roberts, Stella; Rooney, Christopher; Wilcox, Mark; Warren, Simon; Ellis, Joanna; Gopal, Robin; Dunning, Jake; Zambon, Maria; Hopkins, Susan.
  • Brown CS; National Infection Service, Public Health England, London, United Kingdom. Electronic address: colin.brown@phe.gov.uk.
  • Clare K; National Infection Service, Public Health England, London, United Kingdom.
  • Chand M; National Infection Service, Public Health England, London, United Kingdom.
  • Andrews J; Department of Microbiology, Whittington Health NHS Trust, London, United Kingdom.
  • Auckland C; Royal Devon & Exeter NHS Foundation Trust, Exeter, United Kingdom.
  • Beshir S; The Hospital of St John & St Elizabeth, London, United Kingdom.
  • Choudhry S; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • Davies K; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • Freeman J; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom; University of Leeds, Leeds, United Kingdom.
  • Gallini A; The Hospital of St John & St Elizabeth, London, United Kingdom.
  • Moores R; The Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Patel T; Department of Microbiology, Whittington Health NHS Trust, London, United Kingdom.
  • Poznalska G; Royal Devon & Exeter NHS Foundation Trust, Exeter, United Kingdom.
  • Rodger A; The Royal Free London NHS Foundation Trust, London, United Kingdom; Institute for Global Health, UCL London, United Kingdom.
  • Roberts S; Royal Devon & Exeter NHS Foundation Trust, Exeter, United Kingdom.
  • Rooney C; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom; University of Leeds, Leeds, United Kingdom.
  • Wilcox M; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom; University of Leeds, Leeds, United Kingdom.
  • Warren S; The Royal Free London NHS Foundation Trust, London, United Kingdom; The Royal National Orthopaedic Hospital, Stanmore, United Kingdom.
  • Ellis J; National Infection Service, Public Health England, London, United Kingdom.
  • Gopal R; National Infection Service, Public Health England, London, United Kingdom.
  • Dunning J; National Infection Service, Public Health England, London, United Kingdom; The Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Zambon M; National Infection Service, Public Health England, London, United Kingdom.
  • Hopkins S; National Infection Service, Public Health England, London, United Kingdom.
J Infect ; 81(3): 427-434, 2020 Sep.
Artículo en Inglés | MEDLINE | ID: covidwho-628179
Preprint
Este artículo de revista científica es probablemente basado en un preprint previamente disponible, por medio del reconocimiento de similitud realizado por una máquina. La confirmación humana aún está pendiente.
Ver preprint
ABSTRACT

BACKGROUND:

Significant nosocomial transmission of SARS-CoV-2 has been demonstrated. Understanding the prevalence of SARS-CoV-2 carriage amongst HCWs at work is necessary to inform the development of HCW screening programmes to control nosocomial spread.

METHODS:

Cross-sectional 'snapshot' survey from April-May 2020; HCWs recruited from six UK hospitals. Participants self-completed a health questionnaire and underwent a combined viral nose and throat swab, tested by Polymerase Chain Reaction (PCR) for SARS-CoV-2 with viral culture on majority of positive samples.

FINDINGS:

Point prevalence of SARS-CoV-2 carriage across the sites was 2.0% (23/1152 participants), median cycle threshold value 35.70 (IQR32.42-37.57). 17 were previously symptomatic, two currently symptomatic (isolated anosmia and sore throat); the remainder declared no prior or current symptoms. Symptoms in the past month were associated with threefold increased odds of testing positive (aOR 3.46, 95%CI 1.38-8.67; p = 0.008). SARS-CoV-2 virus was isolated from only one (5%) of nineteen cultured samples. A large proportion (39%) of participants reported symptoms in the past month.

INTERPRETATION:

The point-prevalence is similar to previous estimates for HCWs in April 2020, though a magnitude higher than in the general population. Based upon interpretation of symptom history and testing results including viral culture, the majority of those testing positive were unlikely to be infectious at time of sampling. Development of screening programmes must balance the potential to identify additional cases based upon likely prevalence, expanding the symptoms list to encourage HCW testing, with resource implications and risks of excluding those unlikely to be infectious with positive tests.

FUNDING:

Public Health England.
Asunto(s)

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Personal de Salud / Infecciones por Coronavirus / Transmisión de Enfermedad Infecciosa / Betacoronavirus Tipo de estudio: Estudio de cohorte / Estudios diagnósticos / Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Límite: Adulto / Anciano / Femenino / Humanos / Masculino / Middle aged / Young_adult País/Región como asunto: Europa Idioma: Inglés Revista: J Infect Año: 2020 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Personal de Salud / Infecciones por Coronavirus / Transmisión de Enfermedad Infecciosa / Betacoronavirus Tipo de estudio: Estudio de cohorte / Estudios diagnósticos / Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Límite: Adulto / Anciano / Femenino / Humanos / Masculino / Middle aged / Young_adult País/Región como asunto: Europa Idioma: Inglés Revista: J Infect Año: 2020 Tipo del documento: Artículo